According to a study across all 32 cancer types, data suggest that 66% of mutations leading to cancer are the result of random events.
Clinical trials and drug approvals in the past several years have dramatically improved bladder cancer treatment.
Urologic Cancers News
Researchers developed a novel Bayesian adaptive randomization method that maximizes efficiency by focusing the algorithm to reduce uncertainty within patient-treatment baskets.
More Urologic Cancers Information
A diagnosis of bladder cancer can leave you and your loved ones feeling uncertain, anxious and overwhelmed.
A diagnosis of renal cell cancer can leave you and your loved ones feeling uncertain, anxious and overwhelmed.
This fact sheet reviews a rare type of kidney cancer and research currently being conducted in this area.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Bladder-sparing Therapy Outcomes Similar to Cystectomy in Bladder Cancer
- Prostate Cancer Risk and Fruit Intake
- In Focus: Atezolizumab for Non-small Cell Lung Cancer
- Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients
- PSA Density More Accurate Than PSA for Predicting Prostate Cancer
- Everolimus, Exemestane Safety Profile Same With Prior Chemo in Breast Cancer
- Lung Cancer: Timing May Affect EGFR mutation-related ctDNA Test Results
- Adding Bevacizumab to Chemo May Prolong Survival in Recurrent Ovarian Cancer
- Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD
- Lenalidomide Prolongs PFS Among Elderly Patients With DLBCL